CATX vs PTC · $280.6M cap vs P/E 48, rev $2.74B
Perspective Therapeutics Inc. (CATX) versus PTC Inc (PTC) — a side-by-side from cached financials, not a winner call.
Perspective Therapeutics Inc. (CATX) is a medical devices company listed on US.
PTC Inc (PTC) is a software - application company listed on US.
CATX does not have a complete income-statement cache yet.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
CATX currently screens at market cap $280.6M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Not investment advice. Open the CATX and PTC stock pages for the full models.
Not investment advice.